Brokerages Set Wright Medical Group NV (NASDAQ:WMGI) Price Target at $30.58

Shares of Wright Medical Group NV (NASDAQ:WMGI) have earned a consensus rating of “Hold” from the thirteen ratings firms that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating and eleven have assigned a hold rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $30.58.

A number of analysts have issued reports on WMGI shares. Stifel Nicolaus lowered shares of Wright Medical Group from a “buy” rating to a “hold” rating and set a $30.00 price target on the stock. in a research note on Wednesday, August 26th. BidaskClub upgraded shares of Wright Medical Group from a “strong sell” rating to a “sell” rating in a research note on Wednesday, September 9th. Needham & Company LLC reiterated a “hold” rating on shares of Wright Medical Group in a research note on Wednesday, July 29th. Finally, TheStreet upgraded shares of Wright Medical Group from a “d+” rating to a “c-” rating in a research note on Tuesday, July 14th.

NASDAQ:WMGI traded down $0.02 on Wednesday, reaching $30.53. 1,157,069 shares of the company’s stock were exchanged, compared to its average volume of 2,121,810. The company has a quick ratio of 0.54, a current ratio of 0.82 and a debt-to-equity ratio of 0.90. The firm has a market capitalization of $3.96 billion, a price-to-earnings ratio of -28.80, a price-to-earnings-growth ratio of 6.59 and a beta of 0.61. The business has a fifty day moving average of $30.21 and a 200-day moving average of $29.46. Wright Medical Group has a 52-week low of $19.04 and a 52-week high of $30.66.

Wright Medical Group (NASDAQ:WMGI) last issued its quarterly earnings results on Wednesday, July 29th. The medical device company reported ($0.29) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.07 by ($0.36). The business had revenue of $129.00 million for the quarter. Wright Medical Group had a negative return on equity of 3.86% and a negative net margin of 16.59%. As a group, equities analysts anticipate that Wright Medical Group will post 0.42 earnings per share for the current year.

In other Wright Medical Group news, insider Tim Lanier sold 2,299 shares of the stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $29.39, for a total value of $67,567.61. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Jennifer S. Walker sold 2,110 shares of the stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $29.54, for a total transaction of $62,329.40. The disclosure for this sale can be found here. Insiders sold 15,216 shares of company stock worth $453,090 over the last quarter. 3.80% of the stock is currently owned by insiders.

A number of institutional investors have recently made changes to their positions in WMGI. Advisor Group Holdings Inc. purchased a new position in Wright Medical Group during the 1st quarter worth $33,000. Captrust Financial Advisors raised its holdings in Wright Medical Group by 104.3% during the second quarter. Captrust Financial Advisors now owns 5,468 shares of the medical device company’s stock worth $163,000 after purchasing an additional 2,792 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in Wright Medical Group by 124.7% in the second quarter. PNC Financial Services Group Inc. now owns 7,436 shares of the medical device company’s stock valued at $221,000 after purchasing an additional 4,127 shares during the period. Jane Street Group LLC purchased a new stake in Wright Medical Group in the 2nd quarter valued at approximately $289,000. Finally, DekaBank Deutsche Girozentrale boosted its holdings in Wright Medical Group by 41.0% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 11,000 shares of the medical device company’s stock valued at $317,000 after purchasing an additional 3,200 shares in the last quarter.

Wright Medical Group Company Profile

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

Further Reading: What are the economic characteristics of a bear market?

Analyst Recommendations for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.